Thus, POLE could function as a predictive biomarker for the early diagnosis, aggressive progression, and immune-excluded tumor microenvironment of HCC, especially the for Asian, male, low-risk HCC patients. The gene discussed is POLE; the disease is hepatocellular carcinoma.